Question 1

How much would I have if I DCA'd $100/week into NVS for 5 years?

Accepted Answer

Dollar cost averaging $100 per week into NVS for 5 years (261 purchases) would have resulted in a total investment of $26,100 and a current value of $36,006, a return of 38%. Using Enhanced DCA, which concentrates buys during dips, the same $100/week base deployed $25,644 and grew to $38,487 — a 50% return.

Question 2

What is the best DCA strategy for NVS?

Accepted Answer

Backtesting shows Enhanced DCA — which increases buy amounts during market dips and reduces or skips buys when NVS is overextended — outperformed standard weekly DCA by 12% over 5 years. The enhanced strategy achieved a 50% return vs 38% for standard DCA.

Question 3

What would $100/week into NVS be worth after 3 years?

Accepted Answer

Investing $100 per week into NVS for 3 years (157 purchases, $15,700 total) would have grown to $19,185 — a 22% return. Enhanced DCA over the same period returned 27%.

Question 4

Is DCA into NVS worth it?

Accepted Answer

Based on a 5-year backtest, DCA into NVS returned 38% with standard weekly purchases. An intelligent DCA strategy that buys more during dips returned 50% over the same period — a 12% gain in return, while deploying a similar or smaller amount of capital.

Question 5

How many shares of NVS would I have after DCA for 5 years?

Accepted Answer

Dollar cost averaging $100/week into NVS for 5 years would result in approximately 250 shares with a standard DCA approach (avg entry $104). Enhanced DCA targeting dips results in 268 shares at an average entry of $96.

Question 6

How does NVS DCA compare to the S&P 500?

Accepted Answer

Enhanced DCA into NVS returned 50% over the past 5 years. The S&P 500 (SPY) returned approximately 53% over the same period. NVS's performance reflects its volatility as a healthcare asset. Enhanced DCA outperformed standard DCA by 12%, demonstrating the value of intelligent entry timing during market dips.

Question 7

What is the risk of dollar cost averaging into NVS?

Accepted Answer

Past backtest performance does not guarantee future results. NVS is a healthcare asset whose price can fall as well as rise. While DCA reduces timing risk by spreading purchases over time, losses are still possible if the price declines significantly. Always invest within your risk tolerance and consider your overall portfolio diversification.

Question 8

What is the Novartis AG dollar cost averaging strategy?

Accepted Answer

Standard DCA invests a fixed amount ($100/week or $433/month) into NVS at regular intervals. Enhanced DCA improves on this by using RSI (Relative Strength Index) signals to increase buy amounts during market dips (oversold conditions) and reduce or skip purchases when the stock is overextended. Over the 5-year backtest, this timing approach has delivered 12% higher returns than standard DCA while deploying less total capital into NVS.

Period	Standard DCA	Enhanced DCA	Alpha
1-Year	-1%	1%	+2%
3-Year	22%	27%	+5%
5-Year	38%	50%	+12%

NVS DCA Backtest — Dollar Cost Averaging Results

NVS DCA Results: Key Findings

Alpha you missed while unsubscribed

Dollar cost averaging into NVS — backtest results

Buying the dips for Novartis AG